Corrigendum to 'The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study' [Eur J Heart Fail 2022;24:205-214]
- PMID: 35665579
- PMCID: PMC9434931
- DOI: 10.1002/ejhf.2564
Corrigendum to 'The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study' [Eur J Heart Fail 2022;24:205-214]
Erratum for
-
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.Eur J Heart Fail. 2022 Jan;24(1):205-214. doi: 10.1002/ejhf.2369. Epub 2021 Nov 21. Eur J Heart Fail. 2022. PMID: 34806261 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
